EMFAT
Emerald Mutual Fund Advisers Trust’s ANI Pharmaceuticals ANIP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-145,276
| Closed | -$8.43M | – | 241 |
|
|
2023
Q3 | $8.43M | Hold |
145,276
| – | – | 0.51% | 87 |
|
|
2023
Q2 | $7.82M | Sell |
145,276
-161,001
| -53% | -$8.67M | 0.42% | 90 |
|
|
2023
Q1 | $12.2M | Sell |
306,277
-25,414
| -8% | -$1.01M | 0.72% | 63 |
|
|
2022
Q4 | $13.3M | Sell |
331,691
-6,707
| -2% | -$270K | 0.83% | 54 |
|
|
2022
Q3 | $10.9M | Sell |
338,398
-18,467
| -5% | -$594K | 0.69% | 62 |
|
|
2022
Q2 | $10.6M | Buy |
356,865
+57,372
| +19% | +$1.7M | 0.61% | 68 |
|
|
2022
Q1 | $8.42M | Buy |
299,493
+210,002
| +235% | +$5.9M | 0.37% | 95 |
|
|
2021
Q4 | $4.12M | Buy |
+89,491
| New | +$4.12M | 0.15% | 133 |
|
|
2014
Q4 | – | Sell |
-104,134
| Closed | -$2.95M | – | 214 |
|
|
2014
Q3 | $2.95M | Hold |
104,134
| – | – | 0.28% | 108 |
|
|
2014
Q2 | $3.59M | Buy |
104,134
+41,857
| +67% | +$1.44M | 0.33% | 100 |
|
|
2014
Q1 | $1.95M | Buy |
+62,277
| New | +$1.95M | 0.19% | 123 |
|